Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesVectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Amgen, 09/23/09
Amgen announced detailed results from the Phase 3 '181' trial evaluating Vectibix in combination with FOLFIRI, as a second–line treatment for metastatic colorectal cancer. In this trial, Vectibix significantly improved progression–free survival in patients with KRAS wild–type mCRC.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Sponsor
Article Search
Sponsor